Aberrant RET expression affects normal mammary gland post-lactation transition, enhancing cancer potential
Authors:
- Sabrina A. ValloneSVSabrina A. Vallone
- Martín García SoláMSMartín García Solá
- Carolina Schere-LevyCSCarolina Schere-Levy
- Roberto P. MeissRMRoberto P. Meiss
- Gladys N. HermidaGHGladys N. Hermida
- Lewis A. ChodoshLCLewis A. Chodosh
- Edith C. KordonEKEdith C. Kordon
- Nancy E. HynesNHNancy E. Hynes
- Albana GattelliAGAlbana Gattelli
Open Access
- 29 March 2022
- journal article
- research article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 15 (3)
Abstract
RET is a receptor tyrosine kinase with oncogenic potential in the mammary epithelium. Several receptors with oncogenic activity in the breast are known to participate in specific developmental stages. We found that RET is differentially expressed during mouse mammary gland development: RET is present in lactation and its expression dramatically decreases in involution, the period during which the lactating gland returns to a quiescent state after weaning. Based on epidemiological and pre-clinical findings, involution has been described as tumor promoting. Using the Ret/MTB doxycycline-inducible mouse transgenic system, we show that sustained expression of RET in the mammary epithelium during the post-lactation transition to involution is accompanied by alterations in tissue remodeling and an enhancement of cancer potential. Following constitutive Ret expression, we observed a significant increase in neoplastic lesions in the post-involuting versus the virgin mammary gland. Furthermore, we show that abnormal RET overexpression during lactation promotes factors that prime involution, including premature activation of Stat3 signaling and, using RNA sequencing, an acute-phase inflammatory signature. Our results demonstrate that RET overexpression negatively affects the normal post-lactation transition.Keywords
Funding Information
- Agencia Nacional de Promoción Científica y Tecnológica (PICT-2017-1268)
- Fundación Para el Progreso de la Medicina (GF N°02)
This publication has 79 references indexed in Scilit:
- Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cellsEMBO Molecular Medicine, 2013
- Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancerBreast Cancer Research and Treatment, 2013
- Conditional deletion of Stat3 in mammary epithelium impairs the acute phase response and modulates immune cell numbers during post‐lactational regressionThe Journal of Pathology, 2011
- Focal Adhesion Kinase (FAK) Binds RET Kinase via Its FERM Domain, Priming a Direct and Reciprocal RET-FAK Transactivation MechanismJournal of Biological Chemistry, 2011
- Mammary Gland Growth Factors: Roles in Normal Development and in CancerCold Spring Harbor Perspectives in Biology, 2010
- Stat5 Promotes Survival of Mammary Epithelial Cells through Transcriptional Activation of a Distinct Promoter in Akt1Molecular and Cellular Biology, 2010
- Mechanical strain induces involution-associated events in mammary epithelial cellsBMC Cell Biology, 2009
- Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expressionBreast Cancer Research, 2009
- Mammary Involution and Breast Cancer Risk: Transgenic Models and Clinical StudiesJournal of Mammary Gland Biology and Neoplasia, 2009
- Mammary development in the embryo and adult: a journey of morphogenesis and commitmentDevelopment, 2008